---
permalink: /
title: "About Me"
excerpt: "About Me"
description: "Nathan C. Frey, PhD is CTO & Co-Founder at Coefficient Bio, building for the future in AI-native biotech. Former Group Leader &Principal Scientist at Genentech's Prescient Design, ICLR Outstanding Paper Award winner, with 20+ publications in AI drug discovery and autonomous therapeutic design."
author_profile: true
redirect_from:
  - /about/
  - /about.html
---

## Current

**CTO & Co-Founder**, [Coefficient Bio](https://coefficientbio.com/) (2024-present)

**Scientific Advisor**, [Atomscale](https://www.atomscale.ai/) and [Guide Labs](https://www.guidelabs.ai/)

## Previous Positions

**Principal Machine Learning Scientist & Group Leader**, [Prescient Design](https://www.gene.com/scientists/our-scientists/prescient-design) â€¢ [Genentech](https://www.gene.com/scientists/our-scientists/nathan-frey) (2021-2024)
- Led Foundation Models for Drug Discovery Team (Frey Lab)
- Inventor and co-lead, [Lab-in-the-loop](https://www.biorxiv.org/content/10.1101/2025.02.19.639050v1.abstract) autonomous antibody design system

**Postdoctoral Associate**, MIT (2021)

**Affiliate Scientist**, Materials Project, Lawrence Berkeley National Laboratory

## Education

**Ph.D., Materials Science & Engineering**, University of Pennsylvania (2016-2021)
- National Defense Science & Engineering Graduate Fellow
- S.J. Stein Dissertation Prize (2021)

## Awards & Recognition

- **ICLR Outstanding Paper Award** (2024) - Protein Discovery with Discrete Walk-Jump Sampling
- **National Defense Science & Engineering Graduate Fellowship** (2016-2021)
- **S.J. Stein Dissertation Prize**, University of Pennsylvania (2021)
- **Geoffrey Belton Memorial Fellowship** (2019)
- **PhD Career Exploration Fellowship**, Merck Quantitative Biosciences (2020)
- **Howard Hughes Medical Institute C3 Fellowship** (2013)
- **NSF Undergraduate Research Fellowship** (2012)
- **Phi Beta Kappa** (2014)

## Research Impact

- **20+ peer-reviewed publications** in _Science Advances_, _Nature Machine Intelligence_, _ACS Nano_, _JACS_, _Chemistry of Materials_
- **Conference publications** at ICLR, NeurIPS, ICML
- **Citation metrics**: h-index and citation counts available on [Google Scholar](https://scholar.google.com/citations?user=IMUja60AAAAJ)

## Expertise

**AI for Drug Discovery**: Foundation models, generative modeling, autonomous design systems, active learning, lab-in-the-loop optimization

**Protein Engineering**: Antibody design, structure prediction, therapeutic optimization, binding affinity prediction

**Machine Learning**: Neural scaling laws, discrete diffusion models, energy-based models, graph neural networks, protein language models

**Computational Methods**: High-throughput screening, property prediction, molecular simulation, materials informatics
